Indranil Dey
Principal Financial, Accounting & Executive Officer, President, CEO and DirectorMr. Indranil Dey, also known as Neil, serves as the Chief Executive Officer, President and Director of Bluejay Diagnostics, Inc. and serves as its Principal Financial & Accounting Officer from March 29, 2024 and serves as its Principal Executive Officer Mr. Dey co-founded Bluejay Diagnostics in 2015 and served as its Chief Operating Officer, Treasurer and Secretary. He co-founded Lana Management and Business Research International, LLC (“LMBRI”) in 2007. During his tenure with LMBRI, he spent consulting with Toray Industries, Hitachi Chemicals (now Showa denko Materials Co. Ltd.). Fuji Chemicals, among others. He held a number of executive roles. From 2005-2007 he was Vice President of Business Development and Market for Definines, AG (acquired by AstraZeneca). From 2001 to 2005 he was Head of Business Development, Western U.S. for IMPATH, Inc. where he was responsible for three business units and the introduction of new product Her2neu diagnostics for breast cancer treatment with Herceptin. His past positions include Chief Business Officer for Genmethrax, Inc. Manager, Technology Licensing, Thomas Jefferson Medical University, Manager, Technology Licensing, Ciba Geigy (Novartis). Mr. Dey earned both Bachelor of Science and Master of Science degrees in Biochemistry from Visva-Bharati University in India and a Ph.D. in Lipid Membrane Biochemistry from Biological Research Center in Hungary. He also earned a Masters in Business Administration (Fulbright Scholarship) from the University of Cambridge.
公司職務
- 公司名稱Bluejay Diagnostics, Inc.股票代碼BJDX職務Principal Financial, Accounting & Executive Officer, President, CEO and Director
